Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 7, 2012; 18(9): 979-985
Published online Mar 7, 2012. doi: 10.3748/wjg.v18.i9.979
Figure 2
Figure 2 Growth inhibition assay of gastric cancer cells treated with oxaliplatin. Survival of gastric cancer cells is tested by 3-(4,5-cimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. Each bar represents the mean ± SD. All experiments were repeated three times with similar results (aP < 0.05 vs MKN-45-NC, bP < 0.05 vs KATO-III-NCi).